
Tapra 37.5mg/325mg Tablet
Marketer
Affy Pharma Pvt Ltd
Salt Composition
Tramadol (37.5mg) + Paracetamol (325mg)
Overview Tapra 37.5mg/325mg Tablet
Combiflex 37.5mg/325mg tablets offer dual pain relief for moderate to severe discomfort. Dosage and treatment duration should strictly follow your physician's instructions. Consumption may be with or without food; however, if stomach upset occurs, take with food. Consistent dosing is crucial; complete the prescribed course unless otherwise advised by your doctor. Discontinuing use prematurely requires medical consultation. Potential side effects, including nausea, vomiting, dry mouth, dizziness, and constipation, are usually transient and mild. Report any rash or allergic response immediately. Pregnant individuals, those planning pregnancy, or breastfeeding mothers should consult their doctor before use.
Uses of Tapra 37.5mg/325mg Tablet
Significant to intense pain
Major Benefits of Tapra 37.5mg/325mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tapra 37.5mg/325mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Tapra 37.5mg/325mg Tablet:
- Nausea
- Vomiting
- Constipation
- Dizziness
- Dryness in mouth
- Sleepiness
- Diarrhea
- Abdominal pain
- Dyspepsia
- Flatulence
- Headache
- Trembling
- Anxiety
- Sleep disorder
- Itching
How to use Tapra 37.5mg/325mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tapra 37.5mg/325mg tablets can be consumed with or without food, though consistent timing is recommended.
How Tapra 37.5mg/325mg Tablet works:
Combiflam 37.5mg/325mg tablets contain tramadol and paracetamol, providing relief from intense pain. Tramadol, an opioid analgesic, diminishes pain sensation by interrupting pain signals to the brain. Paracetamol acts by inhibiting the production of pain-inducing chemical mediators.
SAFETY ADVICE
AlcoholUNSAFE
Combining Tapra 37.5mg/325mg tablets with alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Tapra 37.5mg/325mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is recommended.
Breast feedingSAFE IF PRESCRIBED
Taking Tapra 37.5mg/325mg tablets while breastfeeding is likely safe. Available data from humans indicates minimal risk to the infant. However, seek immediate medical attention if your baby exhibits excessive sleepiness, feeding difficulties, respiratory issues, or decreased muscle tone.
DrivingUNSAFE
Taking Tapra 37.5mg/325mg tablets might impair driving ability due to potential side effects.
KidneyCAUTION
Patients with kidney impairment should use Tapra 37.5mg/325mg Tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Tapra 37.5mg/325mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. The medication is contraindicated for individuals experiencing severe or active liver disease.
What if you forget to take Tapra 37.5mg/325mg Tablet :
Should you forget a Tapra 37.5mg/325mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tapra 37.5mg/325mg Tablet
| Label | Value |
|---|---|
| Potential for Dependence | Affirmative. |
| Medication Classification | Pain relievers |
